cancer-immunotherapy

Documents about cancer-immunotherapy

• Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy.#312730NCBI PubMed Central
• Adaptive resistance in cancer immunotherapy#324006Springer Nature OA
• Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy#390932ClinicalTrials.gov
• Engineered Bacterial Membranes as Next-Generation Platforms for Cancer Immunotherapy.#412196NCBI PubMed Central
• Current landscape of RNA chemistry and delivery in cancer immunotherapy.#452820NCBI PubMed Central
• Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling#652785HAL (France)
• Patient Care Needs and the Decision-Making Experience of Patients With Cancer and Family Caregivers Regarding Immunotherapy: A Qualitative and Quantitative Mixed Methods Study#851405ClinicalTrials.gov
• A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy#121341ClinicalTrials.gov
• A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)#353269ClinicalTrials.gov
• Universal Cancer Peptide-based Vaccination in Metastatic NSCLC#847498ClinicalTrials.gov
• <i>Streptomyces</i>-linked exercise gene networks orchestrate immune exclusion and determine immunotherapy response in hepatocellular carcinoma#473114PLOS
• Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)#851063ClinicalTrials.gov
• A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies#417550ClinicalTrials.gov
• Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients#287556ClinicalTrials.gov
• Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)#394749ClinicalTrials.gov
• Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer#859470ClinicalTrials.gov
• Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study#178175HAL (France)
• Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial#146453ClinicalTrials.gov
• NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts#180366ClinicalTrials.gov
• PSMA Therapy and Immunotherapy in Kidney Cancer#184847ClinicalTrials.gov
• Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities#217008ClinicalTrials.gov
• Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer#249581ClinicalTrials.gov
• Tumor Growth Rate (TGR) Predicts Clinical Outcomes for Advanced Non-small Cell Lung Cancer Undergoing Immunotherapy.#256868ClinicalTrials.gov
• Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases#268014ClinicalTrials.gov
• Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors#303750ClinicalTrials.gov
• Efficacy and Safety of Immunotherapy in Non-small Cell Lung Cancer With Uncommon Histological Type#363599ClinicalTrials.gov
• Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas#411258ClinicalTrials.gov
• Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients#448282ClinicalTrials.gov
• Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC#640550ClinicalTrials.gov
• [18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy#847290ClinicalTrials.gov
• A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.#864134ClinicalTrials.gov
• The immunological fitness of NSCLC patients drives the response to anti-PD1-based immunotherapy regardless of age#652989IRIS
• Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer#831480ClinicalTrials.gov
• Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined with Immunotherapy: a Multicenter, Observational Study#869559ClinicalTrials.gov
• QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy#195318ClinicalTrials.gov
• First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer#217038ClinicalTrials.gov
• QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy#394767ClinicalTrials.gov
• Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment#454038ClinicalTrials.gov
• Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC#858680ClinicalTrials.gov
• Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab#217005ClinicalTrials.gov
• I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy#136313ClinicalTrials.gov
• Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer#283025ClinicalTrials.gov
• High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer#866538ClinicalTrials.gov
• Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy#18609ClinicalTrials.gov
• Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC#148733ClinicalTrials.gov
• Radiotherapy combined with immunotherapy for esophageal cancer: current status and challenge.#152179NCBI PubMed Central
• Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy#158225ClinicalTrials.gov
• Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies#181744ClinicalTrials.gov
• INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer#230432ClinicalTrials.gov
• Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives.#242229NCBI PubMed Central